Irritable Bowel Syndrome: Current Approach to Symptoms, Evaluation, and Treatment
Section snippets
Gastrointestinal Symptoms
The main symptom of IBS is chronic or recurrent abdominal pain or discomfort associated with altered bowel habits. The new Rome III criteria for the diagnosis of IBS were published in 2006 and are listed in Box 1 [1]. The following are not part of the diagnostic criteria but are considered supportive symptoms: abnormal stool frequency (<3 bowel movements per week or >3 bowel movements per day); abnormal stool form (lumpy-hard stool or loose-watery stool); defecation; straining; urgency; a
Diagnostic Evaluation of Irritable Bowel Syndrome
The diagnosis of IBS is symptom-based because there are not yet diagnostic biomarkers for IBS. The symptom-based Rome III criteria had a sensitivity of 0.707 and a specificity of 0.878 in the validation sample of 328 patients who had received a clinical diagnosis of IBS [40]. Although the presence of “red flag” or alarm signs and symptoms may indicate a need for further diagnostic work-up, it is not recommended that patients with red flag symptoms be excluded from the diagnosis of IBS. On
Patient-Centered Care
A good health care provider–patient relationship is the cornerstone of effective care of IBS. The quality of this relationship has been shown to improve patient outcomes [51]. Elements of a good provider-patient relationship include a nonjudgmental patient-centered interview, a careful and cost-effective evaluation, inquiry into the patient's understanding of the illness, patient education, and involvement of the patient in treatment decisions [6]. Because IBS is a chronic disease, it is
Summary
IBS is a prevalent and heterogeneous disorder and patient care should be focused on reducing costs and improving patient satisfaction and HRQOL. The cultivation of a trusting and cooperative clinician-patient relationship reduces the ordering of unnecessary diagnostic tests and facilitates a collaborative effort of patient and clinician to find the treatment that provides the most relief of symptoms, and the greatest management of their illness and improvement of HRQOL.
References (103)
- et al.
Functional bowel disorders
Gastroenterology
(2006) - et al.
Costs of care for irritable bowel syndrome patients in a health maintenance organization
Am J Gastroenterol
(2001) - et al.
Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective
Am J Gastroenterol
(2003) The functional gastrointestinal disorders and the Rome III process
Gastroenterology
(2006)- et al.
Functional bowel disorders
Gastroenterology
(2006) - et al.
Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea
Am J Gastroenterol
(2003) - et al.
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?
Gastroenterology
(2002) - et al.
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS
Gastroenterology
(2003) - et al.
AGA technical review on irritable bowel syndrome
Gastroenterology
(2002) - et al.
The presentation of irritable bowel syndrome in the context of somatization disorder
Clin Gastroenterol Hepatol
(2004)
Irritable bowel syndrome: toward an understanding of severity
Clin Gastroenterol Hepatol
What determines severity among patients with painful functional bowel disorders?
Am J Gastroenterol
Gender differences in irritable bowel syndrome
Gastroenterology
Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome
Gastroenterol Clin Biol
Gender-related differences in IBS symptoms
Am J Gastroenterol
Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome
J Psychosom Res
The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review
Am J Gastroenterol
Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?
Gastrointest Endosc
Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis
Gastroenterology
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome
Am J Gastroenterol
Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study
Am J Gastroenterol
Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work
Gastroenterol Clin North Am
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
Gastroenterology
Tegaserod has a favorable safety and tolerability profile in patients with constipation predominant and alternating forms of irritable bowel syndrome
Gastroenterology
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders
Gastroenterology
The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome
Gastroenterology
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles
Gastroenterology
Phase III efficacy and safety of RU-0211, a novel chloride channel activator, for the treatment of constipation
Gastroenterology
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome
Clin Gastroenterol Hepatol
A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome
Am J Gastroenterol
The economic impact of irritable bowel syndrome
Aliment Pharmacol Ther
Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome
Am J Gastroenterol
Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype
Eur J Gastroenterol Hepatol
Review article: the overlap between functional dyspepsia and irritable bowel syndrome—a tale of one or two disorders?
Aliment Pharmacol Ther
Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction
Gut
The role of psychological and biological factors in postinfective gut dysfunction
Gut
Level of chronic life stress predicts clinical outcome in irritable bowel syndrome
Gut
Contributions of anterior cingulate cortex to behaviour
Brain
The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale
Aliment Pharmacol Ther
The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index
Psychosom Med
Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study
Am J Med
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text-Revision
The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome
Am J Gastroenterol
Predictors of patient-assessed illness severity in irritable bowel syndrome (IBS)—DDW abstract
Gastroenterology
Irritable bowel syndrome in developing countries: a disorder of civilization or colonization?
Neurogastroenterol Motil
Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome?
Gut
Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern
Scand J Gastroenterol
Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population
Gut
Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization
Am J Epidemiol
Impact of sex and gender on irritable bowel syndrome
Biol Res Nurs
Cited by (51)
IBS clinical management in Italy: The AIGO survey
2019, Digestive and Liver DiseaseCitation Excerpt :Irritable bowel syndrome (IBS) is quite frequent in the general population, ranging from 5% to 20% [1]. It represents the functional gastrointestinal (GI) disorder most frequently encountered in primary and secondary care [2,3] and it is characterized by abdominal pain and changes in bowel habits (constipation and/or diarrhoea) [4]. It is often associated with other functional digestive and non-digestive disorders [5–7].
Factors which affect the efficacy of hypnotherapy for IBS: Protocol for a systematic review and meta-regression
2018, European Journal of Integrative MedicineCitation Excerpt :Beyond this, concerns exist that outcomes may be subject to a degree of variability dependent upon as yet unexamined factors [51]. Factors that might affect the outcome of hypnotherapy for IBS include the hypnotherapist’s skill, training and experience [10,52]; patient demographics [51], with evidence suggesting that gender may be a factor [53,54], but no meta-analysis has assessed the validity of these findings over different populations. The clinical setting may be a factor [48,52] as may the nature of the hypnotherapeutic approach itself [51].
Effect of warming moxibustion Tianshu (ST 25, bilateral) and Qihai (CV 6) for the treatment of diarrhea-dominant irritable bowel syndrome: A patient-blinded pilot trial with orthogonal design
2017, Journal of Traditional Chinese MedicineCitation Excerpt :The study was approved by the local ethics committee. (a) Meet the Rome II diagnostic criteria;24–26 (b) 30–50 years old, no gender limits; and (c) have not accepted any other treatment recently and is compliant. (a) Nonfunctional intestinal diseases; (b) severe diseases such as cerebral vessel diseases, liver or kidney diseases; and (c) mental disorders, pregnancy, or lactation.
Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial
2015, Clinical Gastroenterology and HepatologyAntispasmodic Agents
2012, Canine and Feline Gastroenterology